Teligent Net Worth 2010-2021 | TLGT

Interactive chart of historical net worth (market cap) for Teligent (TLGT) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Teligent net worth as of February 21, 2025 is $0B.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.259B 7.05
Dr Reddy's Laboratories (RDY) India $11.219B 21.40
BridgeBio Pharma (BBIO) United States $6.956B 0.00
Bausch Health Cos (BHC) Canada $2.597B 1.91
Supernus Pharmaceuticals (SUPN) United States $1.910B 26.01
Amphastar Pharmaceuticals (AMPH) United States $1.505B 9.05
Personalis (PSNL) United States $0.384B 0.00
Taysha Gene Therapies (TSHA) United States $0.336B 23.43
Assembly Biosciences (ASMB) United States $0.081B 0.00
Sol-Gel Technologies (SLGL) Israel $0.017B 0.00
Evoke Pharma (EVOK) United States $0.008B 0.00